NDC Pharmacologic Class N0000020058 Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0002-1433Trulicity DulaglutideInjection, SolutionSubcutaneousEli Lilly And CompanyHuman Prescription Drug
0002-1434Trulicity DulaglutideInjection, SolutionSubcutaneousEli Lilly And CompanyHuman Prescription Drug
0024-5747Adlyxin LixisenatideInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0024-5761Soliqua 100/33 Insulin Glargine And LixisenatideInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcHuman Prescription Drug
0169-2800Saxenda LiraglutideInjection, SolutionSubcutaneousNovo NordiskHuman Prescription Drug
0169-2911Xultophy 100/3.6 (insulin Degludec And Liraglutide)Injection, SolutionSubcutaneousNovo NordiskHuman Prescription Drug
0169-4060Victoza LiraglutideInjectionSubcutaneousNovo NordiskHuman Prescription Drug
0169-4132Ozempic SemaglutideInjection, SolutionSubcutaneousNovo NordiskHuman Prescription Drug
0169-4136Ozempic SemaglutideInjection, SolutionSubcutaneousNovo NordiskHuman Prescription Drug
0173-0866Tanzeum AlbiglutideInjection, Powder, Lyophilized, For SolutionSubcutaneousGlaxosmithkline LlcHuman Prescription Drug
0173-0867Tanzeum AlbiglutideInjection, Powder, Lyophilized, For SolutionSubcutaneousGlaxosmithkline LlcHuman Prescription Drug
0310-6512Byetta ExenatideInjectionSubcutaneousAstrazeneca Pharmaceuticals LpHuman Prescription Drug
0310-6524Byetta ExenatideInjectionSubcutaneousAstrazeneca Pharmaceuticals LpHuman Prescription Drug
0310-6530Bydureon ExenatideInjection, Suspension, Extended ReleaseSubcutaneousAstrazeneca Pharmaceuticals LpHuman Prescription Drug
0310-6540Bydureon Bcise ExenatideInjection, Suspension, Extended ReleaseSubcutaneousAstrazeneca Pharmaceuticals LpHuman Prescription Drug
50090-3483Trulicity DulaglutideInjection, SolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug
50090-3484Trulicity DulaglutideInjection, SolutionSubcutaneousA-s Medication SolutionsHuman Prescription Drug

There are 17 NDC products with the pharmacologic class Glucagon-like Peptide-1 (GLP-1) Agonists [MoA].